US Patent Issued to Zhejiang Hisun Pharmaceutical, Shanghai Aryl Pharmtech on Oct. 6 for "Quinazoline derivative, or preparation method therefor and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,751,952, issued on Oct. 6, was assigned to Zhejiang Hisun Pharmaceutical Co. Ltd. (Taizhou, China) and Shanghai Aryl Pharmtech Co. Ltd. (Shanghai).

"Quinazoline derivative, or preparation method therefor and use thereof" was invented by Panpan Zhang (Taizhou, China), Chaoying Cheng (Taizhou, China), Zhipeng He (Taizhou, China), Chengcai Lin (Taizhou, China), Linjiang Shao (Taizhou, China), Cheng Ye (Shanghai), Wenjian Qian (Taizhou, China) and Lei Chen (Taizhou, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a substituted quinazoline derivative, a preparation method therefor, a pharmaceutical composition comprising ...